This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian Context.
Journal of endourology · 2025
The Role of Tumor Volume Ratio in Predicting Clinically Significant Prostate Cancer on Transperineal Biopsy.
Journal of endourology · 2025
Prostate cancer detection rate with MRI-targeted biopsy alone using outpatient transperineal prostate biopsy.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
Latest funding
- $1,500,000
Unlocking the Power of Trained Immunity in Cancer
CIHR · 2025 · Principal investigator
11 publications.
Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian Context.
Hesswani C, Avolio PP, Rompre-Brodeur A, Ghai S, Anidjar M, Kinnaird A, Chin J, Perlis N, Soytas M, Mannas M, Ahmad A, Klotz L, Tanguay S, Kassouf W, McPherson V, Aprikian A, Pinto P, Sanchez-Salas R
The Role of Tumor Volume Ratio in Predicting Clinically Significant Prostate Cancer on Transperineal Biopsy.
Avolio PP, Hassan T, Addar A, Alshamsi H, McPherson V, Buffi NM, Lughezzani G, Loutochin O, Rompré-Brodeur A, Anidjar M, Sanchez-Salas R
Prostate cancer detection rate with MRI-targeted biopsy alone using outpatient transperineal prostate biopsy.
Avolio PP, Hassan T, Addar A, Alshamsi H, McPherson V, Loutochin O, Lughezzani G, Buffi NM, Anidjar M, Sanchez-Salas R
Differences in remuneration for urologic services across provinces in Canada.
Afenu E, Chan G, McPherson V, Andrews M, Gotto G, Rapaport D, Campbell J, Welk B
Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsy-proven radio-recurrent localized prostate cancer.
McPherson V, Nair SM, Tin AL, Dewar M, Siddiqui K, Sjoberg DD, Vickers AJ, Eastham J, Chin JL
Prophylactic A-Blockers for Radiotherapy-Induced Lower Urinary Tract Symptoms in Men with Prostate Cancer: A Phase III Randomized Trial.
Niazi T, Kaldany E, Tisseverasinghe S, Malagón T, Bahoric B, McPherson V, Rompre-Brodeur A, Anidjar M
Neoadjuvant versus Concurrent Androgen Deprivation Therapy in Localized Prostate Cancer Treated with Radiotherapy: A Systematic Review of the Literature.
Cartes R, Karim MU, Tisseverasinghe S, Tolba M, Bahoric B, Anidjar M, McPherson V, Probst S, Rompré-Brodeur A, Niazi T
Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience.
Di Lalla V, Elakshar S, Anidjar M, Tolba M, Hassan T, Bahoric B, McPherson V, Probst S, Niazi T
Canadian Urological Association guideline on the management of non-muscle invasive bladder cancer
Bhindi B, Kool R, Kulkarni GS, Siemens DR, Aprikian AG, Breau RH, Brimo F, Fairey A, French C, Hanna N
Canadian Urological Association guideline on the management of non-muscle-invasive bladder cancer – Abridged version
Bhindi B, Kool R, Kulkarni GS, Siemens DR, Aprikian AG, Breau RH, Brimo F, Fairey A, French C, Hanna N
Unlocking the Power of Trained Immunity in Cancer
Principal investigators: Divangahi, Maziar; McPherson, Victor A; Muller, William J; Thanabalasuriar, Ajitha
Keywords: Cancer; Trained Immunity
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Surgery
- Medicine
- Department of Epidemiology and Biostatistics
- Other
Co-authors at McGill University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.